phosphatidylcholines has been researched along with Bronchopulmonary Dysplasia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abele, H; Bernhard, W; Franz, AR; Koch, V; Maas, C; Poets, CF; Raith, M | 1 |
| Bernhard, W; Fehrenbach, H; Gesche, J; Griese, M; Koslowski, R; Ohler, FM; Poets, CF; Pynn, CJ | 1 |
| Badon, T; Burighel, A; Carnielli, VP; Cogo, PE; Pesavento, R; Rosso, F; Sacchetto, E; Verlato, G; Zimmermann, LJ | 1 |
| Benetazzo, A; Carnielli, VP; Cobelli, C; Cogo, PE; Gucciardi, A; Toffolo, GM | 1 |
| D'Ovidio, F; Keshavjee, S; Post, M; Ridsdale, R; Roth-Kleiner, M; Tanswell, AK; Unger, S; Yi, M | 1 |
| Carnielli, VP; Chierici, M; Cobelli, C; Cogo, PE; Mariatoffolo, G; Ori, C; Simonato, M; Stefanutti, G | 1 |
| Carlson, SE; Tolley, EA; Werkman, SH | 1 |
| Andersson, S; Lassus, P; Ristimäki, A; Viinikka, L; Ylikorkala, O | 1 |
| Akino, T; Bry, K; Hallman, M; Merritt, TA | 1 |
| Matsuo, M; Motoike, T; Nakamura, H; Ohashi, T; Sano, K; Takada, S; Tsuneishi, S | 1 |
| Kattner, E; Maier, R; Stevens, P; Waiss, E | 1 |
| Benirschke, K; Berry, C; Bloom, BT; Edwards, D; Hallman, M; Jarvenpaa, AL; Key, T; Merritt, TA; Pohjavuori, M; Sahn, D | 1 |
5 trial(s) available for phosphatidylcholines and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Surfactant disaturated phosphatidylcholine kinetics in infants with bronchopulmonary dysplasia measured with stable isotopes and a two-compartment model.
Topics: Bronchopulmonary Dysplasia; Carbon Radioisotopes; Computer Simulation; Humans; Infant, Newborn; Infant, Premature; Isotope Labeling; Kinetics; Lung; Metabolic Clearance Rate; Models, Biological; Phosphatidylcholines; Pulmonary Surfactants; Radioisotope Dilution Technique | 2005 |
Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
Topics: Bronchopulmonary Dysplasia; Carbon Isotopes; Dexamethasone; Dose-Response Relationship, Drug; Epithelial Cells; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Peroxidase; Phosphatidylcholines; Pulmonary Surfactants; Respiration, Artificial; Respiratory Insufficiency; Risk Factors | 2008 |
Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia.
Topics: alpha-Linolenic Acid; Arachidonic Acid; Body Height; Body Weight; Bronchopulmonary Dysplasia; Docosahexaenoic Acids; Double-Blind Method; Energy Intake; Fatty Acids, Omega-3; Female; Food, Fortified; Humans; Incidence; Infant, Newborn; Infant, Premature; Male; Phosphatidylcholines; Phosphatidylethanolamines; Regression Analysis; Visual Acuity | 1996 |
Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
Topics: Amino Acids; Bronchopulmonary Dysplasia; Female; Glycoproteins; Humans; Immunoblotting; Infant, Newborn; Male; Phosphatidylcholines; Proteolipids; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
Prophylactic treatment of very premature infants with human surfactant.
Topics: Amniotic Fluid; Bronchopulmonary Dysplasia; Clinical Trials as Topic; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphatidylcholines; Phosphatidylglycerols; Pneumothorax; Prospective Studies; Pulmonary Emphysema; Pulmonary Surfactants; Random Allocation; Respiratory Distress Syndrome, Newborn; Sphingomyelins | 1986 |
8 other study(ies) available for phosphatidylcholines and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia.
Topics: Arachidonic Acid; Bronchopulmonary Dysplasia; Chromatography, Liquid; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Female; Fetal Blood; Fetus; Humans; Infant; Infant, Premature; Linear Models; Maternal Nutritional Physiological Phenomena; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Tandem Mass Spectrometry | 2016 |
rhKGF stimulates lung surfactant production in neonatal rats in vivo.
Topics: Alveolar Epithelial Cells; Animals; Animals, Newborn; Betamethasone; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cell Proliferation; Drug Therapy, Combination; Female; Fibroblast Growth Factor 7; Gene Expression; Humans; Infant, Newborn; Lung; Male; Phosphatidylcholines; Pulmonary Surfactants; Rats; Recombinant Proteins; Sex Factors | 2011 |
Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Airway Resistance; Birth Weight; Bronchopulmonary Dysplasia; Carbon Isotopes; Case-Control Studies; Gas Chromatography-Mass Spectrometry; Gestational Age; Half-Life; Humans; Infant, Newborn; Instillation, Drug; Phosphatidylcholines; Pressure; Pulmonary Surfactants; Regression Analysis; Respiration, Artificial; Risk Factors; Severity of Illness Index; Sputum; Time Factors | 2003 |
Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease.
Topics: Aging; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Disease Models, Animal; Female; Humans; Infant, Newborn; Organ Size; Phosphatidylcholines; Pulmonary Alveoli; Pulmonary Emphysema; Pulmonary Surfactants; Rats; Rats, Wistar | 2005 |
Hyaline membrane disease: recent developments.
Topics: Ambroxol; Amniotic Fluid; Bronchopulmonary Dysplasia; Female; Glucocorticoids; Humans; Hyaline Membrane Disease; Infant, Newborn; Oxygen; Phosphatidylcholines; Positive-Pressure Respiration; Pregnancy; Prenatal Diagnosis; Prognosis; Pulmonary Surfactants; Sphingomyelins | 1983 |
Vascular endothelial growth factor in human preterm lung.
Topics: Bronchopulmonary Dysplasia; Chorioamnionitis; Endothelial Growth Factors; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature; Lung; Lymphokines; Osmolar Concentration; Phosphatidylcholines; Pre-Eclampsia; Pregnancy; Sphingomyelins; Suction; Trachea; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Effect of dexamethasone on pulmonary surfactant metabolism in hyperoxia-treated rat lungs.
Topics: Animals; Bronchopulmonary Dysplasia; Dexamethasone; Humans; Infant, Newborn; Lung; Male; Oxygen; Phosphatidylcholines; Proteolipids; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Rats; Rats, Inbred Strains; RNA, Messenger | 1991 |
Lecithin/sphingomyelin ratio from tracheal aspirates and compliance of the respiratory system in infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Follow-Up Studies; Humans; Infant; Infant, Newborn; Lung Compliance; Phosphatidylcholines; Respiratory Distress Syndrome, Newborn; Sphingomyelins; Survival Rate; Trachea | 1990 |